Last reviewed · How we verify

NCT05600816: CHOMP

SurmodiCs Pounce Venous THrOMbectomy System Post Market Clinical Follow Up Study

Not yet recruiting NA Last updated 8 May 2024
What this trial tests

NA trial testing Pounce Venous Thrombectomy System in Peripheral Vascular Occlusive Disease in 40 participants. Not yet recruiting.

Timeline
1 April 2025
Primary endpoint
1 October 2025
1 October 2026

Quick facts

Lead sponsorSurModics, Inc.
PhaseNA
StatusNot yet recruiting
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment40
Start date1 April 2025
Primary completion1 October 2025
Estimated completion1 October 2026

Drugs / interventions tested

Conditions studied

Sponsor

SurModics, Inc.

Who can join

Eligibility, any sex, with Peripheral Vascular Occlusive Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is an open label, prospective, non-randomised, multi-centre post market study of the POUNCE Venous Thrombectomy system for de-clotting in the peripheral vasculature (e.g., iliofemoral veins).

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other SurModics, Inc. trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05600816.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing